Ginkgo Bioworks has acquired Patch Biosciences, which has built an AI platform for sequence design that enables more effective, specific, and durable genetic medicines and was backed by Andreessen Horowitz (a16z) Bio + Health, Casdin Capital, and S32.

See more details on the acquisition here.

Leave a Reply

Your email address will not be published. Required fields are marked *